Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anthocyanin in Dyslipidemia
NCT03415503Phase 3Completed
- Sponsor
- Sun Yat-sen University
- Start
- Oct 2018
- Primary completion
- Oct 2019
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in dyslipidemia, sponsored by Sun Yat-sen University. Primary endpoint: Blood lipids at 12 weeks. Started Oct 2018; status: completed.
02
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT03415503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03415503.